Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Mazdutide.

Research draft

Mazdutide is a dual GLP-1 and glucagon receptor agonist.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Mazdutide is a dual GLP-1 and glucagon receptor agonist.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It combines appetite-related and glucagon-mediated metabolic actions.

Human research

Randomised studies support diabetes and weight-management development; results depend on population and endpoints.

Preclinical & other research

Animal and receptor work examined metabolic activity.

Safety & unknowns

Gastrointestinal effects and heart-rate or metabolic findings require trial-specific assessment.

Regulatory status

The developer reports Chinese authorisation for defined indications; this is not evidence of US or UK approval.

Reported use & evidence

Research profile draft

The supplied Mazdutide profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds